Does the alpha-lipoic acid decrease urinary podocalyxin excretion in type 2 diabetics by inhibiting oxidative stress in vivo?
ALA can provide some protection against glomerular podocyte injury in type 2 diabetics, which may be related partly to its effects in alleviating enhanced OS and strengthening antioxidant ability in vivo.
Collectively, these data suggest that miR-124 functions as a tumor suppressor in esophageal cancer through, at least partially, targeting STAT3 signaling pathway.